The potential of CRL4DCAF1 and KSR1 as therapeutic targets in merlin-deficient meningioma

per Rimmer, Jade Lyons, Baiz, Daniele, Ercolano, Emanuela, Hanemann, Oliver
Publicat a Neuro Oncol (2018)

Synthesis and Characterization of a Novel Prostate Cancer-Targeted PI3 Kinase Inhibitor Prodrug

per Baiz, Daniele, Pinder, Tanya A., Hassan, Sazzad, Karpova, Yelena, Salsbury, Freddie, Welker, Mark E., Kulik, George
Publicat 2012

CBMT-06. HIGH LEVELS OF GATA-4 IN MALIGNANT MENINGIOMA LEAD TO LOWER miR-497~195 CLUSTER EXPRESSION IN TISSUE AND BLOOD

per Negroni, Catarina, Ercolano, Emanuela, Adams, Claire, Baiz, Daniele, Kurian, Kathreena M, Hilton, David, Oliver Hanemann, Clemens
Publicat a Neuro Oncol (2019)

A pilot study to establish non-invasive biomarkers for higher-grade meningioma

per Baiz, Daniele, Negroni, Caterina, Ercolano, Emanuela, L Adams, Claire, Kurian, Kathreena M, A Hilton, David, Hanemann, Oliver C
Publicat a Neuro Oncol (2019)

CSIG-02. TARGETING CONSTITUTIVE ACTIVATION OF THE EGFR-STAT1 AXIS DECREASES PROLIFERATION OF MENINGIOMA TUMOUR CELLS

per Ferluga, Sara, Baiz, Daniele, Ercolano, Emanuela, Sharma, Vikram, Dunn, Jemma, Kurian, Kathreena M, Hilton, David, Oliver Hanemann, Clemens
Publicat a Neuro Oncol (2019)

GATA-4, a potential novel therapeutic target for high-grade meningioma, regulates miR-497, a potential novel circulating biomarker for high-grade meningioma

per Negroni, Caterina, Hilton, David A., Ercolano, Emanuela, Adams, Claire L., Kurian, Kathreena M., Baiz, Daniele, Hanemann, C.Oliver
Publicat a EBioMedicine (2020)

Bortezomib effect on E2F and cyclin family members in human hepatocellular carcinoma cell lines

per Baiz, Daniele, Dapas, Barbara, Farra, Rossella, Scaggiante, Bruna, Pozzato, Gabriele, Zanconati, Fabrizio, Fiotti, Nicola, Consoloni, Lara, Chiaretti, Sara, Grassi, Gabriele
Publicat 2014

Constitutive activation of the EGFR–STAT1 axis increases proliferation of meningioma tumor cells

per Ferluga, Sara, Baiz, Daniele, Hilton, David A, Adams, Claire L, Ercolano, Emanuela, Dunn, Jemma, Bassiri, Kayleigh, Kurian, Kathreena M, Hanemann, Clemens O
Publicat a Neurooncol Adv (2020)

BAD Dephosphorylation and Decreased Expression of MCL-1 Induce Rapid Apoptosis in Prostate Cancer Cells

per Yancey, Dana, Nelson, Kyle C., Baiz, Daniele, Hassan, Sazzad, Flores, Anabel, Pullikuth, Ashok, Karpova, Yelena, Axanova, Linara, Moore, Victoria, Sui, Guangchao, Kulik, George
Publicat 2013

Combination of the PI3K Inhibitor ZSTK474 with a PSMA-Targeted Immunotoxin Accelerates Apoptosis and Regression of Prostate Cancer

per Baiz, Daniele, Hassan, Sazzad, Choi, Young A, Flores, Anabel, Karpova, Yelena, Yancey, Dana, Pullikuth, Ashok, Sui, Guangchao, Sadelain, Michel, Debinski, Waldemar, Kulik, George
Publicat 2013

The Potential of MLN3651 in Combination with Selumetinib as a Treatment for Merlin-Deficient Meningioma

per Lyons Rimmer, Jade, Ercolano, Emanuela, Baiz, Daniele, Makhija, Mahindra, Berger, Allison, Sells, Todd, Stroud, Steve, Hilton, David, Adams, Claire L., Hanemann, C Oliver
Publicat a Cancers (Basel) (2020)

Behavioral stress accelerates prostate cancer development in mice

per Hassan, Sazzad, Karpova, Yelena, Baiz, Daniele, Yancey, Dana, Pullikuth, Ashok, Flores, Anabel, Register, Thomas, Cline, J. Mark, D’Agostino, Ralph, Danial, Nika, Datta, Sandeep Robert, Kulik, George
Publicat 2013

Fibulin-2: A Novel Biomarker for Differentiating Grade II from Grade I Meningiomas

per Sofela, Agbolahan A., Hilton, David A., Ammoun, Sylwia, Baiz, Daniele, Adams, Claire L., Ercolano, Emanuela, Jenkinson, Michael D., Kurian, Kathreena M., Teo, Mario, Whitfield, Peter C., Sahm, Felix, Hanemann, C. Oliver
Publicat a Int J Mol Sci (2021)

β2-adrenoreceptor Signaling Increases Therapy Resistance in Prostate Cancer by Upregulating MCL1

per Hassan, Sazzad, Pullikuth, Ashok, Nelson, Kyle C., Flores, Anabel, Karpova, Yelena, Baiz, Daniele, Zhu, Sinan, Sui, Guangchao, Huang, Yue, Choi, Young A., D’Agostino, Ralph, Hemal, Ashok, von Holzen, Urs, Debinski, Waldemar, Kulik, George
Publicat a Mol Cancer Res (2020)